CN1748742A - 克痒舒凝胶及其制备方法 - Google Patents
克痒舒凝胶及其制备方法 Download PDFInfo
- Publication number
- CN1748742A CN1748742A CN 200510109436 CN200510109436A CN1748742A CN 1748742 A CN1748742 A CN 1748742A CN 200510109436 CN200510109436 CN 200510109436 CN 200510109436 A CN200510109436 A CN 200510109436A CN 1748742 A CN1748742 A CN 1748742A
- Authority
- CN
- China
- Prior art keywords
- add
- gel
- itch
- hour
- eliminatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000003756 stirring Methods 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000006210 lotion Substances 0.000 claims abstract description 23
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 12
- 239000012153 distilled water Substances 0.000 claims abstract description 12
- 235000011187 glycerol Nutrition 0.000 claims abstract description 12
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 12
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 230000008961 swelling Effects 0.000 claims abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000003085 diluting agent Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 239000000499 gel Substances 0.000 claims description 37
- 239000003814 drug Substances 0.000 claims description 31
- 230000007803 itching Effects 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 claims description 14
- 229960001859 domiphen bromide Drugs 0.000 claims description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000004821 distillation Methods 0.000 claims description 12
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 12
- 239000003643 water by type Substances 0.000 claims description 12
- 238000007865 diluting Methods 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 102000011759 adducin Human genes 0.000 claims description 5
- 108010076723 adducin Proteins 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 4
- 230000035876 healing Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 31
- 238000012360 testing method Methods 0.000 description 31
- 210000001215 vagina Anatomy 0.000 description 26
- 206010046914 Vaginal infection Diseases 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 13
- 201000008100 Vaginitis Diseases 0.000 description 10
- 238000007689 inspection Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 9
- 239000008921 jie er yin Substances 0.000 description 8
- 231100001274 therapeutic index Toxicity 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004877 mucosa Anatomy 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 210000003756 cervix mucus Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 201000005630 leukorrhea Diseases 0.000 description 5
- 229940074869 marquis Drugs 0.000 description 5
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010046901 vaginal discharge Diseases 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000008350 Pruritus Vulvae Diseases 0.000 description 4
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 230000001572 anti-trichomonad Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000001387 Causalgia Diseases 0.000 description 2
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010004078 Balanoposthitis Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
症状 | 轻度(分) | 中度(分) | 重度(分) |
主证 | 阴部痒痛 | 外阴阴部不适偶瘙痒(2) | 外阴阴部瘙痒尚能忍受(4) | 外阴阴部瘙痒剧烈难以忍受(6) |
带下量多 | 阴部潮湿不舒(2) | 内裤有污迹尚不需垫卫生巾(4) | 内裤污染明显增加需垫卫生巾(6) | |
次证 | 口苦而腻,纳呆腕闷,小便短少、频数、涩痛 | 有(1)无(0) | ||
舌脉 | 舌质红,苔黄腻,脉象滑或滑数 | 记录具体舌脉不计分值 |
局部体征 | (分) | (分) | (分) |
带下量多,色白稠厚豆渣样 | 阴道分泌物稍多(2) | 阴道后穹隆有堆积分泌物,量多(4) | 全阴道有分泌物并流出阴道口外(6) |
阴道粘膜 | 点片状附着白色膜状物,擦除后粘膜充血(1) | 整个阴道布满膜状物,擦除后粘膜充血、肿胀(2) | 整个阴道布满膜状物,擦除后可见粘膜糜烂、溃破(3) |
外阴 | 充血(1) | 充血、肿胀(2) | 发红、破溃(3) |
局部体征 | (分) | (分) | (分) |
带下量多,色黄稀薄呈泡沫状 | 阴道分泌物稍多(2) | 阴道后穹隆有堆积分泌物,量多(4) | 全阴道有分泌物并流出阴道口外(6) |
肤粘膜及阴道宫颈粘膜 | 充血(1) | 充血、肿胀(2) | 阴道、宫颈粘膜有散在出血点或草莓状突起(3) |
外阴 | 充血(1) | 充血、肿胀(2) | 发红、破溃(3) |
分类 | 致病菌 | |
霉菌性阴道炎 | 霉菌(10) | 无(0) |
滴虫性阴道炎 | 滴虫(10) | 无(0) |
项目 | (分) | (分) | (分) |
阴道涂片 | I度:涂片内主要是阴道上皮细胞及阴道杆菌(0) | II度:涂片内除阴道上皮细胞及阴道杆菌,可见白细胞及其它杂菌(1) | III度:涂片内阴道上皮细胞及阴道杆菌很少,其它杂菌及白细胞较多或只白细胞及其它杂菌(2) |
病种 | 组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 愈显率(%) | 总有效率(%) | U | P |
霉菌 | 试验组 | 60 | 30 | 21 | 5 | 4 | 85 | 93.33 | 1.65 | >0.05 |
对照组 | 60 | 23 | 19 | 10 | 8 | 70.00 | 86.67 | |||
滴虫 | 试验组 | 60 | 12 | 19 | 21 | 8 | 51.67 | 86.67 | 1.56 | >0.05 |
对照组 | 60 | 7 | 16 | 25 | 12 | 38.33 | 81.67 |
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 愈显率(%) | 总有效率(%) | U | P |
试验组 | 120 | 54 | 20 | 36 | 10 | 61.67 | 91.67 | 1.97 | <0.05 |
对照组 | 120 | 37 | 25 | 44 | 14 | 51.67 | 88.33 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101094365A CN100340231C (zh) | 2005-10-18 | 2005-10-18 | 克痒舒凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101094365A CN100340231C (zh) | 2005-10-18 | 2005-10-18 | 克痒舒凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1748742A true CN1748742A (zh) | 2006-03-22 |
CN100340231C CN100340231C (zh) | 2007-10-03 |
Family
ID=36604519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005101094365A Active CN100340231C (zh) | 2005-10-18 | 2005-10-18 | 克痒舒凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100340231C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2445818A (en) * | 2006-09-15 | 2008-07-23 | Japan Atomic Energy Agency | Preparation of gels derived from carboxymethyl cellulose alkali metal salt |
CN101157760B (zh) * | 2006-09-15 | 2012-03-21 | 独立行政法人日本原子力研究开发机构 | 衍生自羧甲基纤维素碱金属盐的凝胶的制备 |
CN103386076A (zh) * | 2012-05-07 | 2013-11-13 | 四川九峰天然药业股份有限公司 | 一种粘膜护理抗菌凝胶组合物及其应用 |
CN105434630A (zh) * | 2014-08-20 | 2016-03-30 | 合肥华威药业有限责任公司 | 一种治疗阴道炎的外用药物及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151881A (zh) * | 1995-12-01 | 1997-06-18 | 陶周行 | 一种阴道冲洗保留剂及其制备工艺与使用方法 |
CN1049145C (zh) * | 1995-12-05 | 2000-02-09 | 李贵华 | 妇女专用消毒液 |
CN1175405A (zh) * | 1996-08-30 | 1998-03-11 | 蒋孟良 | 舒身药浴剂 |
CN1232686A (zh) * | 1998-04-22 | 1999-10-27 | 苏美嘉 | 一种治疗妇科病的外用药 |
CN1071125C (zh) * | 1998-10-12 | 2001-09-19 | 范永昌 | 一种预防和治疗外阴疾病的浴洗药 |
CN1212127C (zh) * | 1999-09-17 | 2005-07-27 | 平顶山市舒莱卫生用品有限公司 | 治疗妇科病的药物卫生用品及其制备方法 |
CN1236805C (zh) * | 2001-09-29 | 2006-01-18 | 罗才良 | 一种治疗皮肤病的中药制剂顽皮膏 |
CN1239185C (zh) * | 2003-11-28 | 2006-02-01 | 温先敏 | 妇科疾病外用洗剂及制备方法 |
-
2005
- 2005-10-18 CN CNB2005101094365A patent/CN100340231C/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2445818A (en) * | 2006-09-15 | 2008-07-23 | Japan Atomic Energy Agency | Preparation of gels derived from carboxymethyl cellulose alkali metal salt |
GB2445818B (en) * | 2006-09-15 | 2011-03-09 | Japan Atomic Energy Agency | Preparation of gels derived from carboxymethyl cellulose alkali metal salt |
CN101157760B (zh) * | 2006-09-15 | 2012-03-21 | 独立行政法人日本原子力研究开发机构 | 衍生自羧甲基纤维素碱金属盐的凝胶的制备 |
CN103386076A (zh) * | 2012-05-07 | 2013-11-13 | 四川九峰天然药业股份有限公司 | 一种粘膜护理抗菌凝胶组合物及其应用 |
CN103386076B (zh) * | 2012-05-07 | 2018-01-12 | 四川九峰天然药业股份有限公司 | 一种粘膜护理抗菌凝胶组合物及其应用 |
CN105434630A (zh) * | 2014-08-20 | 2016-03-30 | 合肥华威药业有限责任公司 | 一种治疗阴道炎的外用药物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100340231C (zh) | 2007-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1187045C (zh) | 用于治疗牛皮癣的物质 | |
CN100340231C (zh) | 克痒舒凝胶及其制备方法 | |
CN1072654C (zh) | 苯甲酰胺衍生物,含所述衍生物的组合物及它们的用途 | |
CN1212134C (zh) | 一种治疗泌尿系统感染和前列腺炎的中药复方制剂 | |
CN1709376A (zh) | 治疗气滞型胃脘痛的中药复方制剂及其制备方法 | |
CN1917895A (zh) | 鱼腥草和插田泡的提取物及其用于预防和治疗过敏性疾病的组合物 | |
CN1231210C (zh) | 黄体酮胶囊组合物及其制备方法 | |
CN101057892A (zh) | 一种治疗阴道疾病的药物组合物及其制备方法和应用 | |
CN1706435A (zh) | 一种治疗经前期紧张综合征的中药组合物及其制备方法 | |
CN100581567C (zh) | 治疗阴道炎洗液的制备方法 | |
CN1559495A (zh) | 鹿胎颗粒中药制剂及生产工艺 | |
CN1813697A (zh) | 盐酸特比萘芬阴道凝胶及其制法和质量控制方法 | |
CN101057952A (zh) | 一种治疗痛经的药物组合物及其制备方法和应用 | |
CN1197612C (zh) | 治疗泌尿系统结石和尿路感染疾病的中药制剂及其制备方法 | |
CN1290529C (zh) | 治疗痛风、高尿酸血症和高脂血症的药物及其制备方法 | |
CN1299734C (zh) | 一种治疗大肠湿热证的中药组合物及其制备方法 | |
CN1742984A (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN1679692A (zh) | 一种治疗淋病的药物及其制备方法 | |
CN1268377C (zh) | 一种提高生物利用度及药效治疗妇科疾病的制剂和制备方法 | |
CN1814221A (zh) | 一种治疗尿路感染的中药组合物及其制备方法 | |
CN1857495A (zh) | 一种治疗痛证的中药复方制剂及其制备方法 | |
CN1923211A (zh) | 一种黄芪甲苷注射液及其制备方法 | |
CN1990022A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN1843396A (zh) | 冠心苏合口腔崩解片及制备方法和质量控制方法 | |
CN1222305C (zh) | 治疗肝肾不足、气阴亏虚的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HEFEI HUAWEI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI GUIHUA Effective date: 20060602 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20060602 Address after: 230088 No. 61, science Avenue, hi tech Development Zone, Anhui, Hefei Applicant after: Hefei Huawei Pharmaceutical Co., Ltd. Address before: 230088 No. 61, science Avenue, hi tech Development Zone, Anhui, Hefei Applicant before: Li Guihua |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 230088 No. 61, science Avenue, hi tech Development Zone, Anhui, Hefei Patentee after: Hefei Huawei Pharmaceutical Co., Ltd. Address before: 230088 No. 61, science Avenue, hi tech Development Zone, Anhui, Hefei Patentee before: Hefei Huawei Pharmaceutical Co., Ltd. |